Shares of Edap Tms Sa (NASDAQ:EDAP) have been given a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.
Brokerages have set a 12 month consensus price objective of $6.50 for the company, according to Zacks. Zacks has also assigned Edap Tms Sa an industry rank of 110 out of 265 based on the ratings given to related companies.
Several research analysts have weighed in on the company. Zacks Investment Research upgraded Edap Tms Sa from a “hold” rating to a “buy” rating and set a $3.25 price target for the company in a report on Tuesday. TheStreet raised shares of Edap Tms Sa from a “sell” rating to a “hold” rating in a research note on Tuesday, September 27th. Finally, HC Wainwright reissued a “buy” rating on shares of Edap Tms Sa in a research note on Tuesday, August 30th.
A hedge fund recently bought a new stake in Edap Tms Sa stock. Perkins Capital Management Inc. acquired a new stake in shares of Edap Tms Sa (NASDAQ:EDAP) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 118,000 shares of the company’s stock, valued at approximately $391,000. Perkins Capital Management Inc. owned about 0.46% of Edap Tms Sa at the end of the most recent reporting period. Institutional investors and hedge funds own 12.11% of the company’s stock.
Shares of Edap Tms Sa (NASDAQ:EDAP) traded down 0.8582% during mid-day trading on Thursday, hitting $2.7958. The stock had a trading volume of 4,150 shares. Edap Tms Sa has a 12-month low of $2.43 and a 12-month high of $6.57. The stock has a market cap of $80.31 million, a P/E ratio of 17.0476 and a beta of 1.12. The company’s 50 day moving average price is $2.90 and its 200 day moving average price is $3.25.
Edap Tms Sa (NASDAQ:EDAP) last issued its quarterly earnings results on Thursday, August 25th. The company reported $0.09 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.03) by $0.12. Edap Tms Sa had a return on equity of 58.61% and a net margin of 11.53%. Equities research analysts predict that Edap Tms Sa will post $0.16 EPS for the current fiscal year.
About Edap Tms Sa
EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.